Key Client Fiduciary Advisors’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,422
Closed -$222K 231
2025
Q2
$222K Sell
1,422
-28
-2% -$4.44K 0.09% 182
2025
Q1
$239K Sell
1,450
-31
-2% -$5.16K 0.11% 165
2024
Q4
$241K Sell
1,481
-22
-1% -$3.94K 0.11% 167
2024
Q3
$294K Buy
1,503
+16
+1% +$2.95K 0.13% 150
2024
Q2
$258K Buy
1,487
+299
+25% +$49.8K 0.13% 152
2024
Q1
$201K Buy
1,188
+35
+3% +$6.56K 0.11% 176
2023
Q4
$228K Buy
+1,153
New +$204K 0.13% 155
2022
Q3
Sell
-1,194
Closed -$205K 117
2022
Q2
$205K Sell
1,194
-53
-4% -$9.17K 0.2% 102
2022
Q1
$235K Sell
1,247
-9
-0.7% -$1.78K 0.19% 111
2021
Q4
$306K Buy
+1,256
New +$275K 0.25% 90

Other funds holding ZTS

Key Client Fiduciary Advisors's ZTS Position: Q3 2025 in Review

Key Client Fiduciary Advisors sold out of Zoetis (ZTS) in Q3 2025, closing a stake of 1,422 shares — an estimated $222K sold.

Key Client Fiduciary Advisors first reported a position in ZTS in Q4 2021 and held it in 10 quarters. The position peaked at $306K in Q4 2021. 1,799 funds tracked by Wall St. Rank hold ZTS as of Q3 2025.

  • Key Client Fiduciary Advisors reported no remaining Zoetis position as of Q3 2025 after selling out during the quarter.
  • Key Client Fiduciary Advisors sold 1,422 Zoetis shares in Q3 2025, an estimated $222K.
  • Key Client Fiduciary Advisors first reported a position in Zoetis in Q4 2021 and held it in 10 quarters.
  • Key Client Fiduciary Advisors's Zoetis position peaked at $306K in Q4 2021.
  • 1,799 funds tracked by Wall St. Rank held Zoetis as of Q3 2025.

Based on Key Client Fiduciary Advisors's 13F filing for Q3 2025, filed 14 Oct 2025.